2025-06-11T12:40:06-05:00 2024-07-31 320530003 QUIGLEY & MIRON 3580 WILSHIRE BLVD 1755 LOS ANGELES CA 90010 990 2023-08-01 464072112 SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK SPON 3606002170 PO BOX 55491 PORTLAND OR 97238 MATTHEW STOLL PHD MD CHAIR 3606002170 2025-06-10 0 ARMEN GRIGORIAN P01582463 2136393550 2023 2025-03-06 01:10:19Z MATTHEW STOLL PHD MD PO BOX 55491 PORTLAND OR 97238 669112 0 X WWW.SPARTANGROUP.ORG X 2013 CA OUR MISSION IS TO FOSTER SPONDYLOARTHRITIS RESEARCH AND EDUCATION IN NORTH AMERICA. WE ACCOMPLISH THIS MISSION BY ENGAGING IN RESEARCH PROJECTS, SUPPORTING YOUNG RESEARCHERS, AND CONDUCTING AN ANNUAL MEETING HIGHLIGHTING IMPORTANT EDUCATION AND RESEARCH PROGRAMS. OUR VISION IS A WORLD FREE OF SPONDYLOARTHRITIS THROUGH LEADERSHIP IN RESEARCH AND EDUCATION. 11 11 0 60 0 0 999000 630000 66600 2750 0 36362 7255 0 1072855 669112 110660 189000 0 0 116163 98400 0 0 0 593460 310608 820283 598008 252572 71104 3043861 2444182 201874 159653 2841987 2284529 X THE MISSION OF SPARTAN IS TO FOSTER RESEARCH AND EDUCATION IN SPONDYLOARTHRITIS IN THE UNITED STATES. SPARTAN MEMBERS ACCOMPLISH THIS MISSION BY ENGAGING IN SPECIFIC RESEARCH PROJECTS AND THROUGH AN ANNUAL MEETING, WHICH HIGHLIGHTS IMPORTANT EDUCATION AND RESEARCH PROGRAMS. 0 0 361595 57000 2750 SPARTAN ANNUAL MEETINGSPARTAN HOLDS AN ANNUAL MEETING TO HIGHLIGHT ADVANCES IN SPONDYLOARTHRITIS RESEARCH AND TREATMENT AND ENCOURAGE POST-DOCTORAL FELLOWS TO ENGAGE IN THE SPARTAN MISSION OF FOSTERING RESEARCH AND EDUCATION IN THE FIELD OF SPONDYLOARTHRITIS (SPA). THE RESEARCH AND EDUCATION MEETING IS ALSO AN OPPORTUNITY TO BRING TOGETHER EXPERT, DEDICATED RESEARCHERS TO IDENTIFY AND ADDRESS UNMET NEEDS IN THE FIELD OF SPA RESEARCH AND THERAPY. THE HYBRID MEETING IS ATTENDED BY SPARTAN MEMBERS FROM THROUGHOUT NORTH AMERICA - WITH ATTENDANCE OF 150 IN CLEVELAND, OHIO AND 50 VIRTUALLY. PRESENTERS IN THE SCIENTIFIC SESSIONS ARE THE PROMINENT INTERNATIONAL EXPERTS IN THEIR FIELDS. THE SPONDYLOARTHRITIS REVIEW COURSE IS A PRE-MEETING WORKSHOP FOR RHEUMATOLOGY FELLOWS, APPS, AND OTHER TRAINEES. WE CONDUCTED AN ULTRASOUND WORKSHOP ATTENDED BY MORE THAN 75 LEARNERS.SPARTAN RESEARCH PROJECTSCLASSIC (CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS INCEPTION COHORT)THE PRIMARY STUDY OBJECTIVE IS TO TEST ("VALIDATE") THE PERFORMANCE OF THE CURRENT ASAS CLASSIFICATION CRITERIA IN A PROSPECTIVE COHORT OF PATIENTS PRESENTING WITH UNDIAGNOSED CHRONIC BACK PAIN TO RHEUMATOLOGISTS AT NORTH AMERICAN SITES IN US, MEXICO, AND CANADA >/= 3 MONTHS DURATION WITH ONSET </= 45 YEARS OF AGE. THE STUDY WAS COMPLETED IN 2024 WITH 500 PATIENTS AT 25 SITES.BASIS (BIOMARKERS IN AXIAL SPONDYLOARTHRITIS INVESTIGATIVE STUDY) THE PRIMARY OBJECTIVE IS TO ESTABLISH A WELL-CHARACTERIZED BIOBANK FOR AXSPA AND IDENTIFY A DIAGNOSTIC BIOMARKER(S) UTILIZING A CROSS-SECTIONAL STUDY OF INDIVIDUALS WITHIN THE SPECTRUM OF AXSPA. THE BASIS STEERING COMMITTEE IS COLLABORATING WITH INDUSTRY PARTNERS AND INTENDS TO LAUNCH THE PROGRAM IN 2025. 132000 132000 SPARTAN GRANTSTHE MISSION OF SPARTAN IS TO ADVANCE RESEARCH AND EDUCATION TO IMPROVE THE CARE OF PATIENTS WITH SPONDYLOARTHRITIS. WE FEEL STRONGLY THAT LAYING THE FOUNDATION FOR THE NEXT GENERATION OF RESEARCHERS AND LEADERS IN SPA IS AN IMPORTANT PORTAL TO ACHIEVE THIS MISSION. THE GOAL OF OUR GRANT PROGRAMS IS TO SUPPORT THE EARLY STAGES OF A FELLOW-LED RESEARCH PROJECT. WITH THE AIM OF ENCOURAGING FELLOWS TO TAKE UP RESEARCH PROJECTS UNDER MENTORS WITH EXPERTISE IN SPA, SPARTAN SUPPORTS TO 2 MENTORED FELLOWSHIP PROJECTS EACH YEAR ($10,000 PER PROJECT - WITH $5000 EACH FOR THE MENTOR AND MENTEE). SPARTAN'S EARLY CAREER INVESTIGATOR AWARD SUPPORTS EARLY CAREER INVESTIGATORS WHO ARE WORKING IN THE FIELD OF AXIAL SPONDYLOARTHRITIS AND HAS BEEN RENAMED THE EARLY CAREER INVESTIGATOR (ECI) AWARD WITH UP TO 2 NEW GRANTS SUPPORTED ($25,000 PER PROJECT PER YEAR FOR TWO YEARS) ANNUALLY. TRAVEL AWARDS GO TO THE TOP 3 ABSTRACTS TO SUPPORT TRAVEL TO INDUSTRY MEETINGS (3 AWARDS @ $1000 EACH). 493595 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 1 1 0 0 0 CA X X LISA SPIEGEL 3606002170 PO BOX 55491 PORTLAND OR 97238 MATTHEW STOLL PHD MD CHAIR 10.00 X X 0 0 0 JOERG ERMANN MD IMMEDIATE PAST CHAIR 3.00 X X 0 0 0 IGNACIO GARCIA-VALLARDES MD DIRECTOR 2.00 X X 0 0 0 SIBA RAYCHAUDHURI MD DIRECTOR 2.00 X 0 0 0 MAUREEN DUBREUIL MD TREASURER 2.00 X X 0 0 0 NIGIL HAROON PHD MD VICE-CHAIR 3.00 X X 0 0 0 JEAN LIEW MD MSC DIRECTOR 3.00 X 0 0 0 MARINA MAGREY MD SECRETARY 2.00 X X 0 0 0 JOHN REVEILLE MD DIRECTOR 2.00 X 0 0 0 MOHAMAD BITTAR MD DIRECTOR 3.00 X 0 0 0 AKIHIRO NAKAMURA MD PHD DIRECTOR 2.00 X 0 0 0 LISA SPIEGEL EXECUTIVE DIRECTOR 30.00 X 106300 0 0 106300 0 0 1 0 0 0 0 510000 120000 630000 ANNUAL MEETING REGISTR 900099 2750 2750 2750 36362 36362 669112 2750 0 36362 97000 97000 57000 57000 35000 35000 98400 98400 1972 1972 2000 2000 25976 25636 340 4768 4587 181 4465 2945 1520 265833 265833 2167 2167 BOARD EXPENSES 3427 3427 598008 493595 104413 0 432349 229432 400000 280800 2211512 1933950 3043861 2444182 201874 159653 201874 159653 X 2596137 2284529 245850 0 2841987 2284529 3043861 2444182 71104 -628562 0 X X 0 0 0 X 1030000 892975 1196324 999000 630000 4748299 1030000 892975 1196324 999000 630000 4748299 3372580 1375719 19537 9766 113 36362 65778 1585 1232 111 7255 10183 4824260 70750 0.28520 0.26970 X 1. SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK (SPARTAN) HAS PUBLIC SUPPORT OF 29% , OVER TWO AND A HALF TIMES THE MINIMUM AMOUNT REQUIRED TO BE A PUBLIC CHARITY. 2. SPARTAN IS A PROFESSIONAL SOCIETY THAT RECEIVES SUPPORT FROM MULTIPLE PHARMACEUTICAL COMPANIES. EACH OF THESE PHARMACEUTICAL COMPANIES ARE PUBLICLY OWNED AND THEREFORE REPRESENT MILLIONS OF INDIVIDUAL SHAREHOLDERS. ADDITIONALLY, SPARTAN'S ACTIVITIES BENEFIT APPROXIMATELY 7 MILLION INDIVIDUALS, WHICH IS VERY SUBSTANTIAL PERCENTAGE OF THE POPULATION OF THE UNITED STATES. MUCH OF SPARTAN'S FOCUS CENTERS ON RESEARCH AND EDUCATION TO IMPROVE THE CARE OF PATIENTS WITH CHRONIC BACK PAIN, AS WELL AS THE TREATMENT OF THOSE IN WHOM THE BACK PAIN IS FOUND TO HAVE AN INFLAMMATORY CAUSE (SPONDYLOARTHRITIS). APPROXIMATELY 8% OF ADULTS HAVE CHRONIC BACK PAIN, AND ABOUT 1% OF THE ADULT POPULATION HAS SPONDYLARTHRITIS. EVEN WITH THE MOST CONSERVATIVE ESTIMATES, MILLIONS OF PEOPLE IN THE UNITED STATES, AND EVEN MORE WORLDWIDE, ARE IMPACTED BY SPARTAN'S ACTIVITIES.3. SPARTAN HAS A GOVERNING BODY MADE UP OF 11 LEADERS IN THE FIELD, WHO EDUCATE THE PUBLIC AND ARE SCIENTISTS AND EXPERTS IN PROVIDING CARE TO PATIENTS WITH BACK PAIN. SPECIFICALLY, WE HAVE A HIGHLY DIVERSE GOVERNING BODY AS EVIDENCED BY (A) GEOGRAPHIC DIVERSITY, WITH BOARD MEMBERS FROM ALL OVER THE UNITED STATES (ALABAMA, CALIFORNIA, MASSACHUSETTS, OHIO, TEXAS, AND UTAH) AS WELL AS CANADA AND MEXICO; AND (B) LEADERS IN BOTH PEDIATRIC (DR. STOLL) AS WELL AS ADULT (NAKEMURA, GARCIA-VALLARDARES, DUBREUIL, ERMANN, HAROON, LIEW, MAGREY, BITTAR, REVEILLE, RAYCHAUDHURI).4. MEDICAL RESEARCH WHICH IS SPONSORED BY SPARTAN IS MADE AVAILABLE TO THE GENERAL PUBLIC AND IS PUBLISHED IN SCHOLARLY JOURNALS. THE RECIPIENTS OF SPARTAN GRANTS ARE REQUIRED TO PUBLISH THEIR HIGH IMPACT WORK IN PEER-REVIEWED MEDICAL JOURNALS. ADDITIONALLY, AS A LEADER IN THE COMMUNITY, SPARTAN DEVELOPED AND PUBLISHED IN 2016 AND UPDATED IN 2019 RECOMMENDATIONS THAT GUIDE TREATMENT OF PATIENTS WITH SPONDYLOARTHRITIS ACROSS THE WORLD. SPARTAN HAS MADE THESE GUIDELINES AVAILABLE WITHOUT CHARGE TO ALL INTERESTED PARTIES, INCLUDING PATIENTS AS WELL AS PROVIDERS AND THIRD-PARTY PAYERS. 5. SPARTAN'S PROGRAMS ARE SPONSORED AND RUN BY MEMBERS OF THE PUBLIC WITH SPECIAL KNOWLEDGE AND EXPERTISE. SPECIFICALLY, THE PHARMACEUTICAL DONORS HAVE SELECTED SPARTAN BASED UPON MUTUAL KNOWLEDGE OF AND INTEREST IN SPONDYLOARTHRITIS. SPARTAN MEMBERS ARE SELECTED ON THE BASIS OF RECOGNIZED EXPERTISE IN TREATMENT, EDUCATION, OR RESEARCH WITHIN THE FIELD OF SPONDYLOARTHRITIS.6. SPARTAN MAINTAINS A COMPREHENSIVE PROGRAM TO ACCOMPLISH ITS CHARITABLE WORK: FOSTERING RESEARCH AND EDUCATION IN SPONDYLOARTHRITIS IN THE UNITED STATES. SPECIFICALLY, SINCE ITS INCEPTION IN 2013, SPARTAN HAS MAINTAINED A PROGRAM TO FUND PILOT AND SEED RESEARCH GRANTS TO SCIENTISTS STUDYING VARIOUS ASPECTS OF SPONDYLOARTHRITIS. ADDING TO THE IMPACT OF THESE GRANTS IS THAT THEY ARE TARGETED TO JUNIOR RESEARCHERS, ENSURING A CONTINUED PIPELINE OF PHYSICIAN SCIENTISTS WHO WILL CARE FOR AND STUDY SPONDYLOARTHRITIS WELL INTO THE FUTURE. ALL GRANT APPLICATIONS ARE REVIEWED BY AN IMPARTIAL, UNCONFLICTED GROUP OF EXPERTS, AND THE DOLLAR VALUE OF THE AWARDS IS COMMENSURATE WITH SIMILAR GRANTS OFFERED BY NON-PROFIT ORGANIZATIONS, INCLUDING ACADEMIC FACILITIES. THE FINAL VOTE TO APPROVE THE GRANTS IS MADE BY THE SPARTAN BOARD OF DIRECTORS DURING ITS REGULARLY SCHEDULED MEETINGS, OF WHICH MINUTES ARE MAINTAINED. ADDITIONALLY, SPARTAN HAS RECURRING EDUCATIONAL PROGRAMS AIMED AT RHEUMATOLOGY TRAINEES, PROVIDERS CARING FOR PATIENTS WITH SPONDYLOARTHRITIS, AND PROVIDERS OUTSIDE RHEUMATOLOGY WHO MAY ENCOUNTER THESE PATIENTS PRIOR TO DIAGNOSIS. THESE ACTIVITIES BENEFIT THE PROFESSIONAL PERFORMANCE OF HEALTH CARE PROVIDERS TAKING CARE OF PATIENTS WITH SPONDYLOARTHRITIS AND OTHER INFLAMMATORY RHEUMATIC DISEASES AND, INDIRECTLY, MILLIONS OF PATIENTS.7. SPARTAN'S REQUESTS FOR MEMBERSHIP ARE DESIGNED TO ENROLL A SUBSTANTIAL NUMBER OF MEMBERS OF THE COMMUNITY. SPECIFICALLY, SPARTAN ENCOURAGES TRAINEES TO JOIN SPARTAN. THERE ARE LEVELS OF MEMBERSHIP THAT INCLUDE PHYSICIANS WITH VARYING LEVELS OF EXPERIENCE AND EXPERTISE IN THE FIELD; INCLUDING RHEUMATOLOGISTS, GASTROENTEROLOGISTS, RADIOLOGISTS AND OPHTHALMOLOGISTS. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANTS TO RECIPIENTS LOCATED IN REGION 35000 0 0 0 0 0 0 35000 0 35000 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES SPONDYLOARTHRITIS RESEARCH GRANT 25000 CASH PAYMENT 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES SPONDYLOARTHRITIS RESEARCH GRANT 10000 CASH PAYMENT 0 0 0 0 0 0 0 PART I, LINE 3: CASH BASIS 0 OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK RD PORTLAND OR 97239 931176109 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 7000 FANNIN ST HOUSTON TX 77030 741761309 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT CHOP RESEARCH INSTITUTE LOCKBOX 1457 PO BOX 8500 PHILADELPHIA PA 191781457 232237932 501C(3) 10000 0 SPONDYLOARTHRITIS RESEARCH GRANT UNIVERSITY OF WASHINGTON BOX 354966 SEATTLE WA 981954966 916001537 25000 0 SPONDYLOARTHRITIS RESEARCH GRANT THE CHILDREN'S HOSPITAL CORPORATION 300 LONGWOOD AVENUE BOSTON MA 021155724 042774441 501C(3) 10000 0 SPONDYLOARTHRITIS RESEARCH GRANT 2 3 FACULTY AWARDS 17 55000 TRAVEL AWARDS 2 2000 FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS REVIEWED THE FORM 990 PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12 EACH DIRECTOR, PRINCIPAL OFFICER, AND COMMITTEE MEMBER ANNUALLY SIGNS A STATEMENT WHICH: 1) AFFIRMS THAT THE PERSON HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY, HAS READ AND UNDERSTOOD THE POLICY, AND HAS AGREED TO COMPLY WITH THE POLICY; AND 2) DISCLOSES THAT PERSON'S INTERESTS THAT COULD REASONABLY GIVE RISE TO CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION'S AUDIT COMMITTEE HAS RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF THE INDEPENDENT AUDITOR, SUBJECT TO THE APPROVAL OF THE BOARD OR DIRECTORS.